Resveratrol ameliorates imiquimod-induced psoriasis-like skin inflammation in mice

PLoS ONE

Volumn 10, Issue 5, 2015, Pages

  Kjær, Thomas Nordstrøm ^a,b   Thorsen, Kasper ^a,b   Jessen, Niels ^a,b   Stenderup, Karin ^a,b   Pedersen, Steen Bønløkke ^a,b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

IMIQUIMOD; INTERLEUKIN 17; INTERLEUKIN 19; MESSENGER RNA; RESVERATROL; RETINOIC ACID; AMINOQUINOLINE DERIVATIVE; INTERLEUKIN DERIVATIVE; NONSTEROID ANTIINFLAMMATORY AGENT; STILBENE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DERMATITIS; DISEASE SEVERITY; GENE EXPRESSION; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PSORIASIS; SIGNAL TRANSDUCTION; ANIMAL; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HUMAN; PATHOLOGY;

ANIMALIA; MUS;

AMINOQUINOLINES; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKINS; MALE; MICE; PSORIASIS; SIGNAL TRANSDUCTION; STILBENES;

EID: 84930662069     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0126599     Document Type: Article

References (42)

1. Naldi L (2004) Epidemiology of psoriasis. Curr Drug Targets Inflamm Allergy 3: 121-128. PMID: 15180464
2. Perera GK, Di MP, Nestle FO (2012) Psoriasis. Annu Rev Pathol 7: 385-422. doi: 10.1146/annurevpathol-011811-132448 PMID: 22054142
3. Cohen AD, Sherf M, Vidavsky L, Vardy DA, Shapiro J, Meyerovitch J (2008) Association between psoriasis and the metabolic syndrome. A cross-sectional study. Dermatology 216: 152-155. doi: 10.1159/000111512 PMID: 18216477
4. Gottlieb AB, Armstrong AW (2013) Psoriasis outcome measures: a report from the GRAPPA 2012 annual meeting. J Rheumatol 40: 1428-1433. doi: 10.3899/jrheum.130456 PMID: 23908539
5. Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB, Gelfand JM (2006) Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol 55: 829-835. PMID: 17052489
6. Nestle FO, Kaplan DH, Barker J (2009) Psoriasis. N Engl J Med 361: 496-509. doi: 10.1056/NEJMra0804595 PMID: 19641206
7. Goldminz AM, Au SC, Kim N, Gottlieb AB, Lizzul PF (2013) NF-kappaB: An essential transcription factor in psoriasis. J Dermatol Sci 69: 89-94. doi: 10.1016/j.jdermsci.2012.11.002 PMID: 23219896
8. Pedersen SB, Olholm J, Paulsen SK, Bennetzen MF, Richelsen B (2008) Low Sirt1 expression, which is upregulated by fasting, in human adipose tissue from obese women. Int J Obes (Lond) 32: 1250-1255. doi: 10.1038/ijo.2008.78 PMID: 18560370
9. Blander G, Bhimavarapu A, Mammone T, Maes D, Elliston K, Reich C, et al. (2009) SIRT1 promotes differentiation of normal human keratinocytes. J Invest Dermatol 129: 41-49. doi: 10.1038/jid.2008.179 PMID: 18563176
10. Cullberg KB, Olholm J, Paulsen SK, Foldager CB, Lind M, Richelsen B, et al. (2013) Resveratrol has inhibitory effects on the hypoxia-induced inflammation and angiogenesis in human adipose tissue in vitro. Eur J Pharm Sci.
11. Olholm J, Paulsen SK, Cullberg KB, Richelsen B, Pedersen SB (2010) Anti-inflammatory effect of resveratrol on adipokine expression and secretion in human adipose tissue explants. Int J Obes (Lond) 34: 1546-1553. doi: 10.1038/ijo.2010.98 PMID: 20531350
12. Leiherer A, Mundlein A, Drexel H (2013) Phytochemicals and their impact on adipose tissue inflammation and diabetes. Vascul Pharmacol 58: 3-20. doi: 10.1016/j.vph.2012.09.002 PMID: 22982056
13. Poulsen MM, Vestergaard PF, Clasen BF, Radko Y, Christensen LP, Stodkilde-Jorgensen H, et al. (2013) High-dose resveratrol supplementation in obese men: an investigator-initiated, randomized, placebo-controlled clinical trial of substrate metabolism, insulin sensitivity, and body composition. Diabetes 62: 1186-1195. doi: 10.2337/db12-0975 PMID: 23193181
14. Gustafson CJ, Watkins C, Hix E, Feldman SR (2013) Combination therapy in psoriasis: an evidence-based review. Am J Clin Dermatol 14: 9-25. doi: 10.1007/s40257-012-0003-7 PMID: 23329077
15. van der Fits L, Mourits S, Voerman JS, Kant M, Boon L, Laman JD, et al. (2009) Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis. J Immunol 182: 5836-5845. doi: 10.4049/jimmunol.0802999 PMID: 19380832
16. Bachmanov AA, Reed DR, Beauchamp GK, Tordoff MG (2002) Food intake, water intake, and drinking spout side preference of 28 mouse strains. Behav Genet 32: 435-443. PMID: 12467341
17. Swindell WR, Johnston A, Carbajal S, Han G, Wohn C, Lu J, et al. (2011) Genome-wide expression profiling of five mouse models identifies similarities and differences with human psoriasis. PLoS ONE 6: e18266. doi: 10.1371/journal.pone.0018266 PMID: 21483750
18. Gudjonsson JE, Ding J, Johnston A, Tejasvi T, Guzman AM, Nair RP, et al. (2010) Assessment of the psoriatic transcriptome in a large sample: additional regulated genes and comparisons with in vitro models. J Invest Dermatol 130: 1829-1840. doi: 10.1038/jid.2010.36 PMID: 20220767
19. Potapovich AI, Lulli D, Fidanza P, Kostyuk VA, De LC, Pastore S, et al. (2011) Plant polyphenols differentially modulate inflammatory responses of human keratinocytes by interfering with activation of transcription factors NFkappaB and AhR and EGFR-ERK pathway. Toxicol Appl Pharmacol 255: 138-149. doi: 10.1016/j.taap.2011.06.007 PMID: 21756928
20. Van Belle AB, de HM, Lemaire MM, Hendrickx E, Warnier G, Dunussi-Joannopoulos K, et al. (2012) IL-22 is required for imiquimod-induced psoriasiform skin inflammation in mice. J Immunol 188: 462-469. doi: 10.4049/jimmunol.1102224 PMID: 22131335
21. Vinter H, Iversen L, Steiniche T, Kragballe K, Johansen C (2015) Aldara((R))-induced skin inflammation: studies of patients with psoriasis. Br J Dermatol 172: 345-353. doi: 10.1111/bjd.13236 PMID: 24980460
22. Biedasek K, Andres J, Mai K, Adams S, Spuler S, Fielitz J, et al. (2011) Skeletal muscle 11beta-HSD1 controls glucocorticoid-induced proteolysis and expression of E3 ubiquitin ligases atrogin-1 and MuRF-1. PLoS ONE 6: e16674. doi: 10.1371/journal.pone.0016674 PMID: 21304964
23. Choi W, Miyamura Y, Wolber R, Smuda C, Reinhold W, Liu H, et al. (2010) Regulation of human skin pigmentation in situ by repetitive UV exposure: molecular characterization of responses to UVA and/or UVB. J Invest Dermatol 130: 1685-1696. doi: 10.1038/jid.2010.5 PMID: 20147966
24. Cadoudal T, Glorian M, Massias A, Fouque F, Forest C, Benelli C (2008) Retinoids upregulate phosphoenolpyruvate carboxykinase and glyceroneogenesis in human and rodent adipocytes. J Nutr 138: 1004-1009. PMID: 18492826
25. Chakravarty K, Cassuto H, Reshef L, Hanson RW (2005) Factors that control the tissue-specific transcription of the gene for phosphoenolpyruvate carboxykinase-C. Crit Rev Biochem Mol Biol 40: 129-154. PMID: 15917397
26. Zhang Y, Li R, Chen W, Li Y, Chen G (2011) Retinoids induced Pck1 expression and attenuated insulin-mediated suppression of its expression via activation of retinoic acid receptor in primary rat hepatocytes. Mol Cell Biochem 355: 1-8. doi: 10.1007/s11010-011-0831-4 PMID: 21519922
27. Shin DJ, Joshi P, Hong SH, Mosure K, Shin DG, Osborne TF (2012) Genome-wide analysis of FoxO1 binding in hepatic chromatin: potential involvement of FoxO1 in linking retinoid signaling to hepatic gluconeogenesis. Nucleic Acids Res 40: 11499-11509. doi: 10.1093/nar/gks932 PMID: 23066095
28. Wang A, Liu M, Liu X, Dong LQ, Glickman RD, Slaga TJ, et al. (2011) Up-regulation of adiponectin by resveratrol: the essential roles of the Akt/FOXO1 and AMP-activated protein kinase signaling pathways and DsbA-L. J Biol Chem 286: 60-66. doi: 10.1074/jbc.M110.188144 PMID: 20980258
29. Jiang W, Wang S, Xiao M, Lin Y, Zhou L, Lei Q, et al. (2011) Acetylation regulates gluconeogenesis by promoting PEPCK1 degradation via recruiting the UBR5 ubiquitin ligase. Mol Cell 43: 33-44. doi: 10.1016/j.molcel.2011.04.028 PMID: 21726808
30. Sin TK, Yu AP, Yung BY, Yip SP, Chan LW, Wong CS, et al. (2014) Modulating effect of SIRT1 activation induced by resveratrol on Foxo1-associated apoptotic signalling in senescent heart. J Physiol.
31. Yang J, Kong X, Martins-Santos ME, Aleman G, Chaco E, Liu GE, et al. (2009) Activation of SIRT1 by resveratrol represses transcription of the gene for the cytosolic form of phosphoenolpyruvate carboxykinase (GTP) by deacetylating hepatic nuclear factor 4alpha. J Biol Chem 284: 27042-27053. doi: 10.1074/jbc.M109.047340 PMID: 19651778
32. Korecka JA, van Kesteren RE, Blaas E, Spitzer SO, Kamstra JH, Smit AB, et al. (2013) Phenotypic characterization of retinoic acid differentiated SH-SY5Y cells by transcriptional profiling. PLoS ONE 8: e63862. doi: 10.1371/journal.pone.0063862 PMID: 23724009
33. Russell CB, Rand H, Bigler J, Kerkof K, Timour M, Bautista E, et al. (2014) Gene Expression Profiles Normalized in Psoriatic Skin by Treatment with Brodalumab, a Human Anti-IL-17 Receptor Monoclonal Antibody. J Immunol 192: 3828-3836. doi: 10.4049/jimmunol.1301737 PMID: 24646743
34. Witte E, Kokolakis G, Witte K, Philipp S, Doecke WD, Babel N, et al. (2014) IL-19 Is a Component of the Pathogenetic IL-23/IL-17 Cascade in Psoriasis. J Invest Dermatol 134: 2757-2767. doi: 10.1038/jid.2014.308 PMID: 25046339
35. Li HH, Lin YC, Chen PJ, Hsiao CH, Lee JY, Chen WC, et al. (2005) Interleukin-19 upregulates keratinocyte growth factor and is associated with psoriasis. Br J Dermatol 153: 591-595. PMID: 16120148
36. Finch PW, Murphy F, Cardinale I, Krueger JG (1997) Altered expression of keratinocyte growth factor and its receptor in psoriasis. Am J Pathol 151: 1619-1628. PMID: 9403712
37. Gallagher G (2010) Interleukin-19: multiple roles in immune regulation and disease. Cytokine Growth Factor Rev 21: 345-352. doi: 10.1016/j.cytogfr.2010.08.005 PMID: 20889366
38. Wang F, Smith N, Maier L, Xia W, Hammerberg C, Chubb H, et al. (2012) Etanercept suppresses regenerative hyperplasia in psoriasis by acutely downregulating epidermal expression of interleukin (IL)- 19, IL-20 and IL-24. Br J Dermatol 167: 92-102. doi: 10.1111/j.1365-2133.2012.10961.x PMID: 22458549
39. Papp KA, Leonardi C, Menter A, Ortonne JP, Krueger JG, Kricorian G, et al. (2012) Brodalumab, an anti-interleukin-17-receptor antibody for psoriasis. N Engl J Med 366: 1181-1189. doi: 10.1056/NEJMoa1109017 PMID: 22455412
40. Spuls PI, Hooft L (2012) Brodalumab and ixekizumab, anti-interleukin-17-receptor antibodies for psoriasis: a critical appraisal. Br J Dermatol 167: 710-713. doi: 10.1111/bjd.12025 PMID: 23013312
41. Timmers S, Konings E, Bilet L, Houtkooper RH, van de Weijer T, Goossens GH, et al. (2011) Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. Cell Metab 14: 612-622. doi: 10.1016/j.cmet.2011.10.002 PMID: 22055504
42. Boocock DJ, Faust GE, Patel KR, Schinas AM, Brown VA, Ducharme MP, et al. (2007) Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent. Cancer Epidemiol Biomarkers Prev 16: 1246-1252. PMID: 17548692